Cases of proto-oncogene B-Raf (<i>BRAF</i>) V600E mutation are rare, accounting for 1%-4% of non-small cell lung cancers (NSCLCs), and its clinical features remain unclear. Here, BRAF is linked to non-small cell lung carcinoma.